Data / Form D filings / Vitro Biopharma, Inc.
Vitro Biopharma, Inc.: Form D filings
Vitro Biopharma, Inc., a biotechnology company in Golden, CO, filed 9 Form D notices with the SEC between 2010 and 2025. The latest, on June 11, 2025, reports $100,000 sold of a $15 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4621 TECHNOLOGY DR., Golden, CO, 80403
- Phone
- (866) 848-7627
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 793171
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | New notice | $15,000,000 | $100,000 | $14,900,000 | 1 | May 27, 2025 | sec.gov |
| Dec 1, 2023 | New notice | $3,000,000 | $2,000,000 | $1,000,000 | 1 | Nov 16, 2023 | sec.gov |
| Apr 5, 2023 | Amendment | $2,500,000 | $992,600 | $1,507,400 | 9 | Jan 6, 2023 | sec.gov |
| Jan 23, 2023 | New notice | $405,000 | $405,000 | 5 | Jan 6, 2023 | sec.gov | |
| Oct 20, 2021 | New notice | $10,000,000 | $3,000,000 | $7,000,000 | 1 | Oct 15, 2021 | sec.gov |
| Oct 8, 2020 | Amendment | $3,500,000 | $1,000,000 | $2,500,000 | 10 | Jan 15, 2020 | sec.gov |
| Jan 23, 2020 | New notice | $1,000,000 | $500,000 | $500,000 | 4 | Jan 15, 2020 | sec.gov |
| Sep 30, 2010 | New notice | $30,000 | $30,000 | 2 | Sep 17, 2010 | sec.gov | |
| Jan 6, 2010 | New notice | $87,500 | $87,500 | 3 | Dec 18, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Packs | Director | |
| James Musick | Director | |
| Thomas Ohrt | Executive Officer | |
| Chris Furman | Executive Officer, Director | |
| Caroline Mosessian | Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Jun 9, 2025 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vitro Biopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.